Srini V. Kaveri focuses on Immunology, Immune system, Antibody, IL-2 receptor and Innate immune system. Srini V. Kaveri has included themes like Antigen and Cell biology in his Immune system study. His study in Antibody is interdisciplinary in nature, drawing from both Receptor and Disease.
Srini V. Kaveri has researched IL-2 receptor in several fields, including Experimental autoimmune encephalomyelitis, Immune tolerance, FOXP3 and Antigen-presenting cell. His studies deal with areas such as Proinflammatory cytokine, Microbiology and Mycobacterium tuberculosis as well as Innate immune system. His study in the fields of Aspergillus fumigatus under the domain of Microbiology overlaps with other disciplines such as Cladosporium.
The scientist’s investigation covers issues in Immunology, Antibody, Immune system, Autoantibody and Antigen. His is involved in several facets of Immunology study, as is seen by his studies on Autoimmunity, Inflammation, Immunoglobulin G, Immunotherapy and Antigen-presenting cell. His Antibody research is multidisciplinary, relying on both Molecular biology and Virology.
His work deals with themes such as Receptor and Cell biology, which intersect with Immune system. His Antigen research incorporates elements of CD86, Cytotoxic T cell, IL-2 receptor, Proteomics and CD80. His Innate immune system research focuses on Proinflammatory cytokine and how it connects with Mycobacterium tuberculosis.
His primary scientific interests are in Immunology, Antibody, Immune system, Immunotherapy and Autoantibody. His work is connected to Immunoglobulin G, FOXP3, Innate immune system, Immunoglobulin E and Regulatory T cell, as a part of Immunology. His research integrates issues of T cell, Molecular biology, Antigen and Virology in his study of Antibody.
Srini V. Kaveri does research in Immune system, focusing on Dendritic cell specifically. His study looks at the relationship between Immunotherapy and topics such as Autoimmunity, which overlap with B cell. Srini V. Kaveri studied Autoantibody and Internal medicine that intersect with Lipid peroxidation.
Srini V. Kaveri mostly deals with Immunology, Antibody, Immune system, Immunotherapy and FOXP3. Srini V. Kaveri integrates many fields in his works, including Immunology and Immunologic Factors. His Antibody research is multidisciplinary, incorporating perspectives in Prostaglandin E2, Interleukin 33 and Downregulation and upregulation.
His Immune system research incorporates themes from Autoantibody and Lymphocyte. His Immunotherapy study combines topics from a wide range of disciplines, such as Autoimmunity and B cell. His FOXP3 study incorporates themes from Regulatory T cell, IL-2 receptor, Immune tolerance, Concomitant and Flow cytometry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
Michel D. Kazatchkine;Srini V. Kaveri.
The New England Journal of Medicine (2001)
Surface hydrophobin prevents immune recognition of airborne fungal spores
Vishukumar Aimanianda;Jagadeesh Bayry;Jagadeesh Bayry;Jagadeesh Bayry;Silvia Bozza;Olaf Kniemeyer.
Nature (2009)
Cutting Edge: Human CD4+CD25+ T Cells Restrain the Maturation and Antigen-Presenting Function of Dendritic Cells
Namita Misra;Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Michel D. Kazatchkine.
Journal of Immunology (2004)
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies
Mohan S. Maddur;Mohan S. Maddur;Pierre Miossec;Srini V. Kaveri;Jagadeesh Bayry.
American Journal of Pathology (2012)
Self-reactive antibodies (natural autoantibodies) in healthy individuals
Sébastien Lacroix-Desmazes;Srini V Kaveri;Luc Mouthon;Ahidjo Ayouba.
Journal of Immunological Methods (1998)
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Antonino Nicoletti;Srini Kaveri;Giuseppina Caligiuri;Jean Bariéty.
Journal of Clinical Investigation (1998)
Therapeutic Preparations of Normal Polyspecific IgG (IVIg) Induce Apoptosis in Human Lymphocytes and Monocytes: A Novel Mechanism of Action of IVIg Involving the Fas Apoptotic Pathway
Nagendra K. A. Prasad;Giuliana Papoff;Ann Zeuner;Emmanuelle Bonnin.
Journal of Immunology (1998)
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis
Arthur E. Warrington;Kunihiko Asakura;Allan J. Bieber;Bogoljub Ciric.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Cedric Carbonneil;Namita Misra.
Blood (2003)
Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
Vir-Singh Negi;Sriramulu Elluru;Sophie Sibéril;Stéphanie Graff-Dubois.
Journal of Clinical Immunology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Inserm : Institut national de la santé et de la recherche médicale
Université Paris Cité
Sorbonne University
Université Paris Cité
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
University of Giessen
National Institutes of Health
Université Paris Cité
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
Publications: 101
University of Washington
University of Leicester
Istituto Neurologico Carlo Besta
KU Leuven
Universidade Federal de Goiás
University of Stirling
Linnaeus University
University of Shizuoka
Dartmouth College
Tokyo University of Agriculture
National Oceanic and Atmospheric Administration
Freie Universität Berlin
Columbia University
University of Manchester
Technical University of Munich
Instituto de Salud Carlos III